Promoting partnerships
We work in partnership with strong research-based pharmaceutical companies to develop and commercialise their findings. This is one of the ways we expand our product portfolio with new products that will benefit patients.
Looking for real potential
We investigate many opportunities and our research teams carefully analyse the potential of any product for the patient. We also look closely at commercial viability and regulatory implications.
Main areas of interest
Agreements are primarily made for products ranging from development phase II b (after clinical proof of concept) to approval. But we also commit to earlier products. Although we are interested in all products of benefit, our major therapeutic focus areas are cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management.
We offer our partners:
- Clinical trials
- Intellectual property applications and defence
- Product registration compliance, submission and support
- Pricing and reimbursement
- Quality assurance
- Advisory boards
- Line extensions that increase compliance and convenience for patients and medical professionals